Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Novanta (NOVT) Research & Development (2016 - 2026)

Novanta filings provide 17 years of Research & Development readings, the most recent being $23.3 million for Q2 2026.

  • On a quarterly basis, Research & Development changed 0.06% to $23.3 million in Q2 2026 year-over-year; TTM through Apr 2026 was $95.5 million, a 0.01% change, with the full-year FY2025 number at $95.5 million, changed 0.03% from a year prior.
  • Research & Development hit $23.3 million in Q2 2026 for Novanta, up from $22.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $25.3 million in Q2 2025 to a low of $20.9 million in Q2 2022.
  • Median Research & Development over the past 5 years was $23.2 million (2024), compared with a mean of $23.0 million.
  • Biggest five-year swings in Research & Development: grew 27.33% in 2022 and later decreased 9.56% in 2025.
  • Novanta's Research & Development stood at $21.9 million in 2022, then rose by 7.07% to $23.5 million in 2023, then grew by 7.82% to $25.3 million in 2024, then decreased by 9.56% to $22.9 million in 2025, then rose by 1.68% to $23.3 million in 2026.
  • The last three reported values for Research & Development were $23.3 million (Q2 2026), $22.9 million (Q4 2025), and $24.1 million (Q3 2025) per Business Quant data.